Genprex is advancing its novel gene therapies for large patient populations with cancer and diabetes who currently have limited treatment options AUSTIN, Texas, March 23, 2023 /PRNewswire/ — Rodney Varner, CEO of Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX), a clinical-stage…